Board PG - Search Results

1

Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo.

Sun RC, Fadia M, Dahlstrom JE, Parish CR, Board PG, Blackburn AC. Sun RC, et al. Among authors: board pg. Breast Cancer Res Treat. 2010 Feb;120(1):253-60. doi: 10.1007/s10549-009-0435-9. Epub 2009 Jun 19. Breast Cancer Res Treat. 2010. PMID: 19543830

2

Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells.

Sun RC, Board PG, Blackburn AC. Sun RC, et al. Among authors: board pg. Mol Cancer. 2011 Nov 18;10:142. doi: 10.1186/1476-4598-10-142. Mol Cancer. 2011. PMID: 22093145 Free PMC article.

3

Dichloroacetate Prevents Cisplatin-Induced Nephrotoxicity without Compromising Cisplatin Anticancer Properties.

Galgamuwa R, Hardy K, Dahlstrom JE, Blackburn AC, Wium E, Rooke M, Cappello JY, Tummala P, Patel HR, Chuah A, Tian L, McMorrow L, Board PG, Theodoratos A. Galgamuwa R, et al. Among authors: board pg. J Am Soc Nephrol. 2016 Nov;27(11):3331-3344. doi: 10.1681/ASN.2015070827. Epub 2016 Mar 9. J Am Soc Nephrol. 2016. PMID: 26961349 Free PMC article.

4

Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer.

Chen L, Dahlstrom JE, Chandra A, Board P, Rangasamy D. Chen L, et al. Breast Cancer Res Treat. 2012 Nov;136(1):129-42. doi: 10.1007/s10549-012-2246-7. Epub 2012 Sep 29. Breast Cancer Res Treat. 2012. PMID: 23053642 Free PMC article.

5

Phenylalanine-induced leucopenia in genetic and dichloroacetic acid generated deficiency of glutathione transferase Zeta.

Theodoratos A, Tu WJ, Cappello J, Blackburn AC, Matthaei K, Board PG. Theodoratos A, et al. Among authors: board pg. Biochem Pharmacol. 2009 Apr 15;77(8):1358-63. doi: 10.1016/j.bcp.2009.01.017. Epub 2009 Feb 2. Biochem Pharmacol. 2009. PMID: 19426674

6

Dichloroacetic acid up-regulates hepatic glutathione synthesis via the induction of glutamate-cysteine ligase.

Theodoratos A, Blackburn AC, Cappello J, Tummala P, Dahlstrom JE, Board PG. Theodoratos A, et al. Among authors: board pg. Biochem Pharmacol. 2012 Feb 1;83(3):427-33. doi: 10.1016/j.bcp.2011.11.012. Epub 2011 Nov 23. Biochem Pharmacol. 2012. PMID: 22127296

7

The Antiviral Drug Efavirenz in Breast Cancer Stem Cell Therapy.

Chiou PT, Ohms S, Board PG, Dahlstrom JE, Rangasamy D, Casarotto MG. Chiou PT, et al. Among authors: board pg. Cancers (Basel). 2021 Dec 11;13(24):6232. doi: 10.3390/cancers13246232. Cancers (Basel). 2021. PMID: 34944852 Free PMC article.

8

Activation of LINE-1 Retrotransposon Increases the Risk of Epithelial-Mesenchymal Transition and Metastasis in Epithelial Cancer.

Rangasamy D, Lenka N, Ohms S, Dahlstrom JE, Blackburn AC, Board PG. Rangasamy D, et al. Among authors: board pg. Curr Mol Med. 2015;15(7):588-97. doi: 10.2174/1566524015666150831130827. Curr Mol Med. 2015. PMID: 26321759 Free PMC article. Review.

9

Efavirenz as a potential drug for the treatment of triple-negative breast cancers.

Chiou PT, Ohms S, Board PG, Dahlstrom JE, Rangasamy D, Casarotto MG. Chiou PT, et al. Among authors: board pg. Clin Transl Oncol. 2021 Feb;23(2):353-363. doi: 10.1007/s12094-020-02424-5. Epub 2020 Jun 21. Clin Transl Oncol. 2021. PMID: 32566961

10

Testosterone regulation of cyclin E kinase: A key factor in determining gender differences in hepatocarcinogenesis.

Pok S, Barn VA, Wong HJ, Blackburn AC, Board P, Farrell GC, Teoh NC. Pok S, et al. J Gastroenterol Hepatol. 2016 Jun;31(6):1210-9. doi: 10.1111/jgh.13232. J Gastroenterol Hepatol. 2016. PMID: 26574916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

313 results

Search Page

Filters